408-854-1883 starts at $30 per hr home care

Affordable in home care | starts at $28 per hr

Healing power of Thai Curry

20160601_124535.jpg

Ingredients:

Ginger, lemon grass, onions, Thai/Vietnamese Basil leaves, onions, garlic, coconut milk, mushrooms, green bell peppers, and other ingredients in the Thai curry mix paste, sea salt,other herbs of your choice

Note: All of the above ingredients can effect positive detox and healing to the body since most of them are rich in anti-oxidants and sulfur-based for cleansing the circulatory system and body.  You may add cooked fish or hard tofu in the mixture.

Cooking instruction

  1. Slice all ingredients in similar shape, easy to chew and appealing to the senses.
  2. Heat the olive oil in the cooking pot (stainless steel preferred).
  3. Sautee garlic, onions and the rest of the ingredients
  4. Add the coconut milk (add one fourth water or less) and set to boil with added curry paste. I used the red thai curry paste.

Serve with love and warm rice.

Restore your hearing naturally by Dr Mercola

If you have trouble hearing, or notice that your hearing is not as good as it used to be, listen up.

Age-related hearing loss may be retrievable, according to Dr. Jonathan Wright, MD, medical director of the Tahoma Clinic in Washington.

Bioidentical hormone aldosterone

By supplementing three patients with the bioidentical hormone aldosterone, all of the men who were either losing their hearing or who had lost a lot of their hearing  were able to regain much of what had been lost.

In one case, an 87-year-old man who was diagnosed with hearing loss in 1994 was found to have low aldosterone levels. After six weeks of taking aldosterone, the man visited his audiologist and found that his hearing had increased 30-50 decibels in one ear, and 20-30 in the other. His ability to discriminate words from a noisy background also increased significantly.

An animal study has also suggested that the hormone aldosterone was able to restore hearing.

This process of using bioidentical hormones to restore hearing is actively going on at the Tahoma Clinic, which is presently the first and only place in the United States that is using aldosterone to restore hearing.

Sources:
 

In the mid 70’s, Dr. Wright was the editor of one of the best alternative medical periodicals of that time, called Prevention Magazine. It was so influential, in fact, that as a result of one of the articles in there, I became inspired to actually pursue osteopathic medical training as an alternative to traditional medicine.

I view Dr. Wright as one of the major pioneers in helping to educate physicians about the natural medicine paradigm. It’s interesting to notice just how ingrained the conventional view on medicine and medical science really is; conventional medicine is said to be backed, and proven by science.

But the reality is that only 15 percent of all things done in current medicine have ever been proven by a controlled clinical trial. 15 percent…

This shocking fact has been repeatedly confirmed and published by such entities as the Office of Technology Assessment (a branch under a different name of the U.S. Congress), and by Duke University Research Sciences, just to name a couple of the sources.

In truth, there’s just as much scientific proof on natural medicine as there is in conventional medicine, but this fact is simply ignored and under reported because techniques such as those of Dr. Wright will not create billions of dollars for the pharmaceutical industry.

What Causes Age-Related Hearing Loss?

Interestingly enough, age-related hearing loss is not due to “mechanical dysfunction” in your ear, but rather it’s how your brain processes information that results in reduced hearing.

From colors and shapes seen, to textures and objects felt, to the range of sounds you hear on the street, your brain does an amazing job of sorting, filtering and making sense of the information that flows through your senses. Your brain stem sorts out the mass of information in ways that make it easy for you to carry on with life. Yet it’s this ability of your brain–not hearing itself–that is diminished as you age and can no longer hear as well.

Furthermore, it’s your brain’s ability to provide proper feedback to your ear, by filtering out unwanted information that declines when you reach your 40s and 50s. Without this “filtering system,” you’re more likely to be overcome by a mass of information that is difficult to sort out.

What is Aldosterone?

Aldosterone is a type of hormone that is essential to life because it regulates the amounts of electrolytes in your body. It is secreted naturally by your adrenal cortex and simultaneously regulates sodium and potassium levels, helping to maintain both your blood pressure and bodily fluids.

If aldosterone levels in your body are out of sync, a variety of symptoms can result. Low levels of aldosterone have been indicated in diseases such as diabetes, for example.

As usual, we find that your body is amazingly interconnected and being deficient in any nutrient, anti-oxidant, vitamin, mineral or hormone can lead to a whole host of physical dysfunctions. Which is why I consistently try to impart the importance of whole nutrition and whole health; eating a diet based on your individual nutritional type, getting proper sleep (since your body performs a wide variety of restorative functions during that time), and getting sufficient exercise.

By the way, while we’re on the subject of hormones, I’d like to remind you that women who take the most common form of hormone replacement therapy (HRT) have been found to experience a hearing loss of 10 to 30 percent more than those who do not.

Women whose HRT included progestin (a synthetic form of progesterone) had the hearing loss usual for women up to a decade older, and showed problems both in the inner ear, and in the portions of the brain used for hearing.

How You Can Protect Yourself Against Hearing Loss

While aging is a natural part of life, it’s important to realize there are many things you can do to keep your body young and healthy. It’s not a quick fix and there is some effort involved, but the rewards are well worth the effort.

I find Dr. Wright’s experience to be an amazing testimony to the power of your body and brain to overcome what is traditionally believed to be irreversible processes, and it reinforces other scientific findings that hearing loss may be either prevented, or greatly restored, through all natural means.

Using energy psychology tools like EFT, for example, can also be useful if you are struggling with hearing loss.

Other studies have showed that a combination of vitamins A, C, and E, as well as magnesium, can protect your hearing.

In one animal study, a high-dose mixture of these vitamins were given to the animals an hour before exposure to a loud noise, and then taken once a day for five days thereafter. Amazingly, the animals were protected from permanent noise-induced hearing loss even after prolonged exposure to sounds as loud as a jet engine taking off at close range!

Of course, protecting yourself from loud noises in the first place is prevention 101.

Sound is created when noise beats against the eardrum and the vibrations stimulate nerves deep inside your ear. There, fine hair cells called cilia convert the vibrations into nerve impulses, which are transmitted to your brain.

Continued exposure to noise of 85 decibels or more will eventually destroy these fragile hair cells in your inner ear that convert sound vibrations into nerve impulses — the basis of hearing. The volume of portable compact disc players ranges between 91 and 121 decibels, and earphones increase the volume. The louder the noise, the quicker the hearing loss.

For instance, 100-decibel stereo headphones can cause harm in two hours, and a 120-decibel rock concert damages the ears in only 7.5 minutes. So, using an inexpensive set of ear plugs during loud noise activities is your first step to prevent damage that is not related to the physical process of aging.

Anti-aging blend of thirty vitamins and minerals

A dietary supplement containing a blend of thirty vitamins and minerals—all natural ingredients widely available in health food stores—has shown remarkable anti-aging properties that can prevent and even reverse massive brain cell loss, according to new research from McMaster University.

It’s a mixture scientists believe could someday slow the progress of catastrophic neurological diseases such as Alzheimer’s, ALS and Parkinson’s.

“The findings are dramatic,” says Jennifer Lemon, research associate in the Department of Biology and a lead author of the study. “Our hope is that this supplement could offset some very serious illnesses and ultimately improve quality of life.”

The formula, which contains common ingredients such as vitamins B, C and D, folic acid, green tea extract, cod liver oil and other nutraceuticals, was first designed by scientists in McMaster’s Department of Biology in 2000.

A series of studies published over the last decade and a half have shown its benefits in mice, in both normal mice and those specifically bred for such research because they age rapidly, experiencing dramatic declines in cognitive and motor function in a matter of months.

The mice used in this study had widespread loss of more than half of their brain cells, severely impacting multiple regions of the brain by one year of age, the human equivalent of severe Alzheimer’s disease.

The mice were fed the supplement on small pieces of bagel each day over the course of several months. Over time, researchers found that it completely eliminated the severe brain cell loss and abolished cognitive decline.

“The research suggests that there is tremendous potential with this supplement to help people who are suffering from some catastrophic neurological diseases,” says Lemon, who conducted the work with co-author Vadim Aksenov, a post-doctoral fellow in the Department of Biology at McMaster.

“We know this because mice experience the same basic cell mechanisms that contribute to neurodegeneration that humans do. All species, in fact. There is a commonality among us all.”

In addition to looking at the major markers of aging, they also discovered that the mice on the supplements experienced enhancement in vision and most remarkably in the sense of smell—the loss of which is often associated with neurological disease—improved balance and motor activity.

The next step in the research is to test the supplement on humans, likely within the next two years, and target those who are dealing with neurodegenerative diseases.

The research is published online in the journal Environmental and Molecular Mutagenesis.

Explore further: ‘Silver bullet’ supplement could slow brain aging

Provided by: McMaster University


Keywords:

  • aging;
  • neurodegeneration;
  • multi-ingredient dietary supplement;
  • oxidative stress;
  • neuroprotectant

Abstract

Transgenic growth hormone mice (TGM) are a recognized model of accelerated aging with characteristics including chronic oxidative stress, reduced longevity, mitochondrial dysfunction, insulin resistance, muscle wasting, and elevated inflammatory processes. Growth hormone/IGF-1 activate the Target of Rapamycin known to promote aging. TGM particularly express severe cognitive decline.

We previously reported that a multi-ingredient dietary supplement (MDS) designed to offset five mechanisms associated with aging extended longevity, ameliorated cognitive deterioration and significantly reduced age-related physical deterioration in both normal mice and TGM.

Here we report that TGM lose more than 50% of cells in midbrain regions, including the cerebellum and olfactory bulb. This is comparable to severe Alzheimer’s disease and likely explains their striking age-related cognitive impairment.

We also demonstrate that the MDS completely abrogates this severe brain cell loss, reverses cognitive decline and augments sensory and motor function in aged mice. Additionally, histological examination of retinal structure revealed markers consistent with higher numbers of photoreceptor cells in aging and supplemented mice.

We know of no other treatment with such efficacy, highlighting the potential for prevention or amelioration of human neuropathologies that are similarly associated with oxidative stress, inflammation and cellular dysfunction.

Environ. Mol. Mutagen., 2016. © 2016 Wiley Periodicals, Inc.

Payment options for Alzheimer’s care

Payment Options — Knowing that there are specialized care options for individuals with dementia is helpful. Since custodial care, by definition, does not need to be provided by a skilled professional, most insurance, including Medicare, will not pay for such care. This becomes quite a quandary for many individuals. For those with financial resources, they can pay privately for the type of care that is necessary. But what happens when the financial resources have been exhausted? How do those individuals without financial means obtain the necessary care? There are some options.

One option is long-term care insurance. Long-term care insurance policies are not standardized like Medicare supplement insurance. These policies can cover a wide continuum of care and must be purchased prior to the onset of a chronic illness.

There are a large variety of companies selling policies with multiple combinations of benefits and coverage. Therefore, when shopping for long-term care insurance policies, it is imperative that:

  • You have thoroughly thought about the type of care that you may desire in the future
  • It is fully understood what is being purchased and what the policy will and will not cover. For example, some policies will only cover nursing home care while others will cover home health care and assisted living care as well. In addition, some policies may often cover care for a specified amount of time (such as 3-5 years) and then the policy will expire.

Another option is seeking assistance from state insurance programs such as Medicaid. Many state insurance programs will cover custodial care in nursing facilities as well as some care in the home and adult family homes. Eligibility for these programs and what types of care they will cover varies between states. To determine eligibility guidelines and the type of care that is covered, contact your local social services office, Area Agency on Aging.

It is wise to speak with an elder law attorney or a financial planner to plan for the future and to determine which options are the most feasible. It is important to know and understand the financial situation so that resources can be managed and budgeted over an extended period of time.

How to Determine the Most Appropriate Care Options – The decision-making processes are often times left to the caregiver. The chosen options must meet the care needs of your loved one, but they must meet your needs as well. Although you want the individual that you are caring for to be as independent as possible, they must be safe and secure. You may want to ask yourself the following questions when faced with a decision:

  • What type of services and assistance do you, the caregiver, need? What types of services will provide you with the most efficient, affordable and necessary assistance?
  • What types of assistance and care does the individual you are caring for need? Some areas in which an individual may need assistance with are:
    • assistance with financial management and banking needs
    • bathing
    • dressing
    • health maintenance such as taking medications as prescribed
    • housekeeping
    • meal preparation
    • mobility
    • supervision
    • toileting
    • transportation
  • Do you have a clear understanding about the individual’s physical, emotional and cognitive strengths and limitations?
  • Do you understand the individual’s preferences regarding the type of care they would like to receive?
  • Are you able to respect their preferences even if they are in conflict with yours as long as the individual will remain safe and have their needs met?
  • Do you have a good understanding of the individual’s financial situation and the type of care and services they can reasonable afford?
  • Is the individual involved as much as possible with the decision making process? Are all individuals that may be impacted by the decision involved in the process?
  • ————–
  • logo
  • Call 408-854-1883 , motherhealth@gmail.com for flexible payment options for your parents with AD or PD in the bayarea.
  • Sometimes, family members can take turns with 2-3 caregivers from our agency to provide 24/7 care for homebound seniors.

Hiring a live-in caregiver

In Canada, you can hire a foreign live-in caregiver. When my sister was in Singapore, she also completed some paperwork from the government of Singapore. In the USA, it would be impossible to hire a foreign live-in caregiver but you can hire a foreign nanny for your children.

To hire a live-in caregiver in the bayarea, contact Motherhealth caregivers at 408-854-1883 and email motherhealth@gmail.com
We will help you search for a caregiver that matches your needs.

There are questions you need to answer for your parents who need a live-in caregiver such as:

  • Describe the healthcare needs of your parents with Alzheimer’s or Parkinson’s
  • Are they wheel chair bound? Are they under hospice care?

I want to hire a foreign worker as a live-in caregiver in Canada. What steps do I take?

Before investing time and money, learn about the conditions of the Live-in Caregiver Program. Be sure it is the best way to meet your needs.

You must first try to hire a Canadian citizen or permanent resident in the available job. When you apply to Employment and Social Development Canada (ESDC) for permission to hire a foreign worker, you will be asked to show what efforts you made in this regard.

If you have been unable to hire a Canadian or permanent resident, your next step is to apply to ESDC for what is known as a Labour Market Impact Assessment (LMIA), which confirms that there is no Canadian worker available to do the job. If ESDC issues you a positive LMIA, you are then authorized to hire a foreign worker.

It also tells you which documents you must give your future employee so that he or she can apply for a work permit through a Canadian visa office outside Canada.

You are responsible for finding a foreign live-in caregiver. To do so, you can use advertisements, personal contacts or hiring agencies.

When you have found a foreign live-in caregiver you want to hire, you must first contact Employment and Social Development Canada (ESDC). If your future employee applies for a work permit and meets the program’s requirements, he or she will receive a work permit. The approval process could take several months. Check the latest information on CIC’s processing times. Your caregiver cannot work for you until CIC approves a work permit showing your name as the employer.

Natural cancer cures


Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 2

S.M. Sagar, MD,* D. Yance, MH, and R.K. Wong, MD*
* Juravinski Cancer Centre and McMaster University (Department of Medicine), Hamilton, Ontario
Center for Natural Healing, Ashland, Oregon, U.S.A
Corresponding author: Stephen M. Sagar, Juravinski Cancer Centre and McMaster University (Department of Medicine), 699 Concession Street, Hamilton, Ontario L8V 5C2. E-mail:ac.no.ccrh@ragas.nehpets

Abstract

The herbalist has access to hundreds of years of observational data on the anticancer activity of many herbs. Laboratory studies are expanding the clinical knowledge that is already documented in traditional texts. The herbs that are traditionally used for anti-cancer treatment and that are anti-angiogenic through multiple interdependent processes (including effects on gene expression, signal processing, and enzyme activities) include Artemisia annua (Chinese wormwood), Viscum album (European mistletoe), Curcuma longa (curcumin), Scutellaria baicalensis (Chinese skullcap), resveratrol and proanthocyanidin (grape seed extract), Magnolia officinalis (Chinese magnolia tree), Camellia sinensis (green tea), Ginkgo biloba, quercetin, Poria cocos, Zingiber officinalis (ginger), Panax ginseng, Rabdosia rubescens hora (Rabdosia), and Chinese destagnation herbs. Natural health products target molecular pathways other than angiogenesis, including epidermal growth factor receptor, the HER2/neu gene, the cyclo-oxygenase-2 enzyme, the nuclear factor kappa-B transcription factor, the protein kinases, the Bcl-2 protein, and coagulation pathways. Quality assurance of appropriate extracts is essential prior to embarking upon clinical trials. More data are required on dose–response, appropriate combinations, and potential toxicities. Given the multiple effects of these agents, their future use for cancer therapy probably lies in synergistic combinations. During active cancer therapy they should generally be evaluated in combination with chemotherapy and radiation. In this role, they act as modifiers of biologic response or as adaptogens, potentially enhancing the efficacy of the conventional therapies or reducing toxicity. Their effectiveness may be increased when multiple agents are used in optimal combinations. New designs for trials to demonstrate activity in human subjects are required. Although controlled trials may be preferable, smaller studies with appropriate endpoints and surrogate markers for anti-angiogenic response could help to prioritize agents for larger, resource-intensive phase iii trials.

Keywords: Angiogenesis, anti-angiogenic, natural health products, herbal medicine, anticancer, clinical trials, integrative, molecular biology

1. INTRODUCTION

The biochemical signalling pathways of angiogenesis form a complex, interconnected web. Inhibition of one part of the web may result in compensation through another pathway. Because botanicals contain a variety of organic chemical complexes, they usually act on multiple targets. A potential advantage of phytochemicals is that they may act through multiple pathways and reduce the development of resistance by cancer cells. This model of pharmacognosy recognizes the advantage of administering the whole plant product to maximize activity. Over-extraction of a specific chemical constituent may remove this therapeutic gain. The challenge for modern pharmacognosy is to ensure that the optimum mixture of chemical constituents is maintained when a product is purified. Usually, such assurance will require a combination of chemical and biologic assays.

The additional anticancer properties of some anti-angiogenic botanicals are briefly discussed here. Their properties may affect various biochemical pathways that indirectly influence angiogenesis. Traditional practice has been to combine multiple natural health products, and scientifically, such combination may provide a therapeutic advantage.

2. MULTISTEP ACTIVITY OF PHYTOCHEMICAL COMPLEXES DERIVED FROM HERBS

2.1 Targeting Alternative Angiogenesis Pathways

The adipocytokines—polypeptides produced by adipocytes—have autocrine, paracrine, and endocrine activities, and are associated with obesity, hyperinsulinemia, and chronic vascular disease as well as with the development of cancer 1. The adipocytokines include vascular endothelial growth factor (vegf), hepatocyte growth factor (hgf), leptin, tumour necrosis factor alpha (tnfα), heparin-binding epidermal growth factor, insulin-like growth factor, and interleukin-6 (IL-6). All can promote angiogenesis.

Curcumin (from turmeric) and epigallocatechin-3 gallate (egcg, from green tea) can inhibit aminopeptidase-N (CD13), a member of the matrix metalloproteinase family that is implicated in the angiogenic switch process 24. Curcumin and egcg can also interfere with the expression of vegf by suppressing a series of activities that promote angiogenesis. These angiogenic pathways include production of transforming growth factor beta (tgfβ), amplification of cyclooxygenase-2 (cox-2) and epidermal growth factor receptor (egfr), aberrant expression of src, and amplification of nuclear factor kappa-B (nfb) signalling. Curcumin, grape seed extract, and green tea constituents may also interfere with endothelial cell function by inhibiting the engagement of specific integrins 5,6. These phytochemicals interact at multiple levels to suppress the inflammatory, hyperproliferative and transformative processes that constitute carcinogenesis.

2.2 Targeting EGFR (HER1)

In many human tumours, egfr is overexpressed. Such overexpression is associated with more aggressive disease, relative resistance to cytotoxic chemotherapy, and a poorer prognosis. Activity of egfr induces angiogenesis 7. Blockade of egfr reduces angiogenesis and cell proliferation 8. Monoclonal antibodies have been developed to block the receptor or the linked intracellular signalling system 915.

Epidermal growth factor (egf) stimulates urokinase-type plasminogen activator (upa) expression, which can promote angiogenesis. Genistein (an isoflavone constituent of soy) and curcumin (a constituent of turmeric) both inhibit the effects of egf 16. In cell cultures, genistein and curcumin inhibit egf-stimulated urokinase production and phosphorylation of egfr. Both botanicals also inhibit protein tyrosine kinases, which could stimulate the enhancement of upa levels induced by tgfβ 17.

Other natural health products that can block activity of egfr include resveratrol 18 and quercetin 1921.

2.3 Targeting HER2/neu

The HER2/neu gene (formerly known as c-erbB-2) is amplified in more than 30% of patients with breast cancer. It is linked to highly aggressive tumours with a poorer prognosis. Overexpression of HER2 is also seen in a significant proportion of patients with other cancer types, including non-small-cell lung cancer, ovarian cancer, prostate cancer, and gastric cancer, in which it may predict a worse outcome 2226. Amplification of the HER2 gene correlates with higher levels of angiogenesis 27.

Herceptin (Genentech, San Francisco, CA, U.S.A.) is a drug that inhibits HER2/neu. It is usually administered adjunctively with cytotoxic chemotherapy. The activity of Herceptin may be further enhanced by oleic acid 28. Emodin, a natural constituent of Polygonum multiflorum and aloe, inhibits HER2/neu expression and is toxic against cancer cells, but nontoxic for normal cells 29.

2.4 Targeting Inflammatory Pathways: COX-2 and NF-κB

Prostaglandins are autacoids derived from arachidonic acid via the cox enzymes. They include prostacyclin, thromboxane, and prostaglandin E types 1–3. A role for arachidonic acid–derived prostaglandins in the process of angiogenesis is now established through in vitro assays. Prostaglandin E2 is a potent inducer of angiogenesis. A correlation exists between cox-2 expression and angiogenesis 30. Neovascularization is blocked by cox-2 antagonists 3136.

The cox-2 and lipoxygenase (lox-5) products of omega-6 fatty acid metabolism may exert stimulatory effects on cancer progression including angiogenesis. The omega-3 fatty acids and some pharmacologic inhibitors of eicosanoid biosynthesis antagonize these effects 3741. Large amounts of omega-3 fatty acids [eicosapentaenoic acid (epa) and docosahexaenoic acid] are found in cold-water fish oils. Liquorice contains glycyrrhizic acid and polyphenols that inhibit cox-2, lox-5, and protein kinase C (pkc) and also downregulate egf 42.

The nfb family consists of closely related protein dimers that bind to a common sequence motif in dna called the κb site. The nfb inducible transcription factor is increased in tissue inflammation, cell proliferation, and cancers. Nuclear factor kappa B induces overactivation of the cox enzymes and is associated with increased angiogenesis 4346.

The cox enzymes are expressed in most normal tissues. The cox-1 enzyme synthesizes non-inflammatory prostaglandins such as prostaglandin E1. In contrast, cox-2 is amplified as part of the inflammatory response and produces prostaglandins such as prostaglandin E2, which may induce uncontrolled cell proliferation and carcinogenesis.

Nuclear factor kappa B may be amplified by growth factors, including tgfβ and basic fibroblast growth factor. Besides nfb, other transcription factors, such as activator protein-1 (ap-1) and IL-6, can stimulate cox-2 transcription. Activator protein-1 also promotes the metastatic phase of tumour cells.

Angiogenesis mediated by cox-2 also has a role in the progression of pre-neoplastic lesions to the invasive phenotype 4750. Conventional cancer therapies—such as radiation, surgery, and chemotherapy—may induce cox-2 amplification as part of the inflammatory response 51. The significance of this induction is unclear, but it could hypothetically reduce therapeutic gain.

Several phytochemical derivatives are potent inhibitors of nfb. These include resveratrol, piceatannol, curcumin, egcg, 6-gingerol (ginger), ursolic acid (holy basil), and ginseng 5256. Many botanical cox-2 inhibiting agents block the amplified activity of the transcription factor nfb without affecting its normal function.

A variety of natural health products can specifically inhibit the cox-2 enzyme and could play a role in reducing tissue toxicity and improving tumour control when used alongside therapies such as radiotherapy, chemotherapy, and surgery (Table I) 57. A botanical that protects an organism from the adverse effects of an intervention is termed an adaptogen. Panax ginseng and curcumin are adaptogens that inhibit cox-2 and that have anti-angiogenic activity derived through the inactivation of nf-κb 55,5861

Table I

Natural health products that inhibit cyclo-oxygenase-2 activity 57

2.5 Targeting Protein Kinases

Oncogenes that encode protein kinases may contribute to the development of cancer. In normal cells, protein kinases are involved in signals between the cell membrane and the nucleus, regulating progression through the cell cycle. Protein kinases control these processes by activating other messenger proteins that can influence cell proliferation.

Mutated kinase genes have been found in a number of malignancies, including chronic myelogenous leukemia and breast and bladder cancers. The mutated kinases can contribute to the development of cancer. In many tumour cells, protein kinases are permanently turned on, forcing the cell into constant division. Examples of abnormal kinases are the abl, src, and cyclin-dependent kinases. The kinases may be amplified or permanently switched on by mutations in the control regions of their genes. A commonly overproduced kinase in cancer is egfr.

Numerous phytochemicals are reported to interfere with cell signalling and may reverse the adverse effects of protein kinase overactivity. Some botanicals with cox-2 inhibitory activity target the intracellular signalling molecules 62,63. Inhibition of specific protein kinases suppresses angiogenesis 6469.

Carnosol and ursolic acid are compounds found in Ocimum sanctum (holy basil) and Rosmarinus officinalis (rosemary) 70. They inhibit the activity of the tyrosine kinases and ornithine decarboxylase 71. Carnosol also reduces nf-κb 72 and the anti-apoptotic protein Bcl-2 73. Genistein and daidzein (isoflavones found in soy) are specific inhibitors of tyrosine kinases 74.

Many phytochemicals appear to selectively react with the regulatory centre of pkc. Curcumin, vitamin E, green tea (catechins), resveratrol, Ganoderma lucidum, and liquorice can inhibit pkc activity 42,7577

2.6 Targeting the Bcl-2 Protein

The signalling protein Bcl-2 plays a key role in the process of controlled cell death called apoptosis, which is necessary to eliminate aged or damaged cells. The Bcl-2 protein is normally found in the mitochondrial membrane, where it regulates the release of cytochrome C. The latter protein can trigger a series of enzymes (caspases) that lead to cell death 7881. High Bcl-2 levels are associated with most types of human cancer and block the release of cytochrome C. They appear to be a contributor to both inherent and acquired resistance to anticancer treatments. The BCL2 and TP53 genes regulate vegf-mediated angiogenesis 82

Curcumin and green tea extract inhibit BCL2 expression 8385. Scutellaria baicalensis contains the phenolic compounds baicalin, baicalein, wogenin, and oroxylin. These constituents inhibit BCL2 overexpression, plus COX2 gene expression and nfb activation 86,87. Hibiscus protocatechuic acid is a phenolic compound isolated from the dried flower of Hibiscus sabdariffa L.; it inhibits Bcl-2 activity 88,89. Other inhibitors of Bcl-2 include epa from fish oil 90, a lectin extract of Viscum album (mistletoe) 91, 6-gingerol 92, grape seed extract 93, echinocystic acid (a triterpene found in ginseng and other Asian herbs) 94,95, parthenolide (a sesquiterpene lactone found in feverfew) 96, and beta-lapachone (a quinone obtained from the bark of the lapacho tree) 9799.

2.7 Targeting Coagulation Pathways Associated with Angiogenesis

In some clinical trials, anticoagulation drugs have been associated with a reduction in metastases 100102. In Chinese medicine, destagnation herbs are traditionally thought to overcome blockages of qi and blood. Laboratory evidence now suggests that these herbs may have anti-angiogenic and anticoagulation properties 103105. A randomized placebo-controlled trial showed that the addition of “destagnation” herbs (including Salvia miltiorrhiza and Angelica sinensis) to radiotherapy doubled both the local control and the survival rate in patients with nasopharyngeal cancer 106.

3. CONCLUSION

Angiogenesis involves multiple interdependent processes operating at the molecular level. These include gene expression, signal processing, and enzyme activities. Most anti-angiogenic natural health products block new vessel formation at multiple levels.

Lack of standardization of screening assays may be an obstacle to defining the most effective products for clinical use. Over-extraction of constituents may negate some of the potential synergy. Quality assurance of appropriate extracts is essential before embarking upon clinical trials.

Most studies of anti-angiogenic activity are based on in vitro or animal work that cannot be readily extrapolated to humans. Phase i and ii studies are required to determine the potential of these substances to improve cytotoxic therapies. Mainly preclinical data exist for most of the naturally derived anti-angiogenic agents. However, because anti-angiogenic agents are mainly cytostatic in nature, the usual paradigm for anticancer drug development, in which tumour response in phase ii trials prompts further development, is not always appropriate. More data are required on dose–response, appropriate combinations, and potential toxicities. Given the multiple effects of these agents, their future use for cancer therapy probably lies in synergistic combinations. They may be evaluated alone for the prevention of cancer recurrence following definitive treatment.

To be suitable for long-term chronic use, these agents should possess minimal toxicity and should be orally administered. However, angiogenesis is also essential for healing of injuries. Most compounds that inhibit tumour angiogenesis are likely to inhibit physiologic angiogenesis, leading to potential side effects such as ulceration and bleeding. Studies are required to determine features that distinguish tumour vessels from normal vessels so that a therapeutic gain can be achieved. Some of the differences have already been described, but the doses and scheduling of anti-angiogenic agents appropriate to achieving the optimum therapeutic gain are unclear.

During active cancer therapy anti-angiogenic agents should generally be evaluated in combination with chemotherapy and radiation. In that role, they act as modifiers of the biologic response and as adaptogens, potentially enhancing the efficacy and reducing toxicity of conventional therapies. The combination of diversity in angiogenic factor expression and different phenotypes of endothelial cells within various tumours is a major challenge for the development of effective anti-angiogenic regimens 107,108. Effectiveness may be increased when multiple agents are used in optimal combinations.

Surrogate markers, such as angiogenic cytokines, are necessary to predict anti-angiogenic response 109. Circulating levels of fibroblast growth factor–2, vegf, vascular cell adhesion molecule–1, endothelial inter-cellular adhesion molecule–1, insulin-like growth factor–1, and cytokines such as interleukin-8 may correlate with tumour angiogenesis 110114. In addition, circulating endothelial cells and their progenitors may be a more reliable marker of response to anti-angiogenic therapies 115,116. Non-invasive functional imaging, such as positron emission tomography and functional magnetic resonance imaging, may play a role 117.

Cell types, methylation cycle, Anti-aging

pcells with epigenetics to DNA.JPG

Are stem cells epigenetic? By Sydney Strupp

Now, note the diagram above. See the blue ball on the top? That represents an iPS cell, an undifferentiated cell that can be determined to become anything. Stem cells are like this cell-many different cell types can come from it. iPS cells are typically seen in a developing zygote. They have a very “clean” DNA, meaning not a lot of epigenetic markers on it until it becomes determined to be a certain kind of cell by cellular determinants in the cytoplasm. So, the iPS cell now spurred by the determinants, travels down the slope into one of the four pockets, becoming that cell. To become that cell type, proteins add methyl groups to certain regions of the DNA and suddenly, by the grace of epigenetics, the unspecialized cell becomes specialized.

The important thing to understand from my rambling nonsense is that all cells start and end with the same DNA, it’s just altered via epigenetic markers. Your kidney cells have the same DNA as your heart. Thankfully, the methyl additions to your DNA are permanent enough to stop a kidney cell from developing in your heart. That’s because heart cells are so specialized uniquely, using an entirely different region of DNA (mostly) that unless the cell had the correct determinants in it’s cytoplasm, the proteins would never add methyl groups for the cell to become that type of cell. They would be at the very bottom of the trough, in one of the deepest pits.

Now, finally getting back to your question. Are stem cells epigenetic? Well, they’re more like the lack of epigenetics. They have very naked DNA that is waiting to be methylated into many different types of cells. They are waiting for the right determinants to “roll them down the hill” into the cell of choice.

Increasing Methylation , one of anti-aging factors

The Methylation Cycle, preventing fatigue and aging

Rich van Konynenburg’s idea is that ineffective methylation is a major cause of fatigue. There are many possible reasons but those that he’s identified for which methylation is essential are:

  • To produce vital molecules such as Co Q-10 and carnitine.
  • To switch on DNA and switch off DNA. This is achieved by activating and deactivating genes by methylation. This is essential for gene expression and protein synthesis. Proteins of course make up the hormones, neurotransmitters, enzymes, immune factors and are fundamental to good health. When viruses attack our bodies, they take over our own DNA in order to replicate themselves. If we can’t switch DNA/RNA replication off then we will become more susceptible to viral infection.
  • To produce myelin for the brain and nervous system.
  • To determine the rate of synthesis of glutathione which is essential for detoxification.
  • To determine the rate of synthesis of glutathione which is an essential anti-oxidant as glutathione-peroxidase. Furthermore oxidative stress blocks glutathione synthesis – yet another vicious cycle!
  • To control sulphur metabolism of the body, not just glutathione but also cysteine, taurine and sulphate. This is an important process for detoxification.
  • As part of folic acid metabolism. This also switches on synthesis of new DNA and RNA.
  • For normal immune function. The methylation cycle is essential for cell mediated immune function and blockages here will mean that infections will not be adequately dealt with. I know this clinically because many patients tell me that once they get on to their B12 injections (an essential co-factor for methylation) this seems to protect them from getting infections.

The overall effect here is that if the methylation cycle doesn’t work, the immune system malfunctions, the detoxification system malfunctions, our ability to heal and repair is reduced and the anti-oxidant system malfunctions.

The Bio-chemistry

(You can ignore this bit if you like because it’s not essential to know but it’s interesting.)

There are four cornerstones to the methylation cycle and on each cornerstone sit four molecules namely homocysteine, methionine, S-adenosylmethionine (SAMe) and S-adenosylhomocysteine. Each of these molecules leads into the next one by means of enzymes. The important co-factors that allow this to happen are the B vitamins such as folic acid, vitamin B12 and vitamin B6. In converting from S-adenosyl methionine into S-adenosyl homocysteine, a methyl group is given up and this can be used to stick on to other molecules – hence the name, the methylation cycle.

However, there is a particular bio-chemical glitch here. In order for the methylation cycle to work these B vitamins have to be in their activated form, namely methylcobalamin, folinic acid and pyridoxyl-5-phosphate. In order to get cobalamin into methylcobalamin, the methylation cycle has to be working. So if this cycle has crashed completely, the body can’t make methylcobalamin in order to get it up and running again. Since this cycle is so fundamental to other biochemical cycles including trans-sulphuration and folate metabolism, it can’t change the vitamin B6, folic acid and cobalamin into the active forms necessary for the methylation cycles to work.

This means that in order to get this cycle up and running initially we have to prime the pump with the activated vitamins, but hopefully once the methylation cycle is up and running, it can function on the vitamins in normal states.

Dr Myhill wrote:

The important cycles which I know to be major players include blood sugar wobbles, allergy problems, sleep cycles, mitochondrial function, anti-oxidant status, the NO/OONO cycle, thyroid and adrenal hormones cycles and de-toxification

We don’t have a simple test to see how well the methylation cycle works. What we can do is measure levels of homocysteine and SAMe

The Methylation Cycle – which supplements to take to support

This is the package of supplements to support the methylation cycle. It needs to be taken in addition to everything else, i.e. the standard nutritional package (multivits, multiminerals, EFAs, vits C + D) and the mitochondrial rescue package (D-ribose, acetyl-L-carnitine, CoQ10, etc.)! But the methylation package will change with time because as the methylation cycle starts to work again, it will start to stand on its own feet. Everyone”s package will be a bit different depending on how poorly their cycle is working. One day we will have the biochemical tests to tailor make each package for each person, but until then I suggest the following regime for those sufferers who have been taking vitamin B12 in oral form (as either hydroxocobalamin or cyanocobalamin):

For two months a daily dose of

  •  Methylcobalamin 1 mg sublingually
  •  Methyltetrahydrofolate 800mcg (ActiFolate)
  •  Pyridoxal-5-phosphate 100mgs (50mgs twice daily)
  •  Glutathione 250mgs daily
  •  Phosphatidyl Serine 200mgs (100mgs twice daily) – BioCare

If you are better – fine! If you are worse – it may be the reaction to the methylation package because it may cause an acute detox reaction (see below). Slow down the regime – take smaller amounts of the supplements and build up slowly. If you are unchanged – swap the sublingual B12 for injected B12 ie:

Daily subcutaneous injections methylcobalamin 0.5mgs (this is a bit more expensive than cyanocobalamin). Some CFSs will not respond clincially until 5mgs daily is injected. B12 is very safe with no known toxicity- as a colleague commented – the only way you could kill yourself with B12 would be to drown in the stuff! I would prefer people to start with this regime but I know many do not fancy the idea of injections – actually I am a wimp too, but they are easy and almost painless.

  •  Methyltetrahydrofolate 800mcg (ActiFolate)
  •  Pyridoxal-5- phosphate 100mgs (50mgs twice daily)
  •  Glutathione 250mgs daily
  •  Phosphatidyl Serine 200mgs (100mgs twice daily) – BioCare

If you are better – fine! If you are worse – it may be the reaction. If you are unchanged, add in:

  •  Tri-methylglycine or TMG (not to be confused with betaine hydrochloride, so always ensure that you are taking pure-grade TMG)
  •  Lecithin (phosphatidyl choline) and Phosphatidyl Ethanolamine.
  •  S-adenosyl methionine (SAMe) directly as a supplement 400mgs daily

 

Why parents are voting for Hillary Clinton and children are voting for Bernie Sanders

I have seen and talked to families in California (bayarea) and found out how they will vote for the Presidential elections. Parents will vote for Hillary and their children will vote for Bernie San…

Source: Why parents are voting for Hillary Clinton and children are voting for Bernie Sanders

Why parents are voting for Hillary Clinton and children are voting for Bernie Sanders

I have seen and talked to families in California (bayarea) and found out how they will vote for the Presidential elections.

Parents will vote for Hillary and their children will vote for Bernie Sanders.

The parents have an income of over $250k per year and are afraid to be taxed more by Bernie while the children are for Bernie because he can change the system with free college and health care system.

The arena is packed by supporters of Bernie Sanders yet the media is not writing about it.

The parents should know that many future policies on health care, drug costs and nursing homes will affect them.

bernie 1.JPG

Meals and medicines/supplements

food drug interaction p2food drug interactionFood and absorption of drugs/supplements

 Food and its constituents may have a significant effect on both the rate and extent of absorption of drugs after oral administration. Understanding the effect of meals on medicines enables health professionals to advise patients about taking medicines with or without food. Co-administration of drugs with food generally delays drug absorption. However, meals may have a variable effect on the extent of absorption – depending on the characteristics of the meal, the drug and its formulation. Some drugs have strict guidelines about when they should be taken in relation to meals. Generally, patients should be advised to take their medicines consistently at the same time with respect to meals.

 Bioavailability and drug interactions with food

 Understanding the possible clinical implications of taking medicines with or without a meal is important for achieving quality use of medicines. Although the effect of food is not clinically important for many drugs, there are food-drug interactions which may have adverse consequences. Often these interactions can be avoided by advising the patient to take their medicines at the same time with respect to meals.

The effect of food on absorption

The formulation of a drug influences its absorption. Food can affect both the rate and extent of absorption (Table 1).

Rate of absorption

Meals slow down gastric emptying and this can delay drug absorption. The composition of the meal influences the rate of gastric emptying – high fat meals lead to delayed gastric emptying. A delay in the drug reaching the small intestine can delay its subsequent absorption into the systemic circulation. Based on these observations, oral administration of a medicine under fasting conditions is often recommended when rapid absorption (and hence rapid onset of therapeutic effect) is needed. For most medicines, especially those used for chronic conditions, a delay in the onset of absorption is of no clinical consequence as long as the amount of drug absorbed is unaffected.

Extent of absorption

Food has the potential to either increase or decrease the extent of drug absorption. Understanding food-drug interaction mechanisms enables the clinician to provide appropriate advice to patients about taking medicines with respect to the timing and composition of meals.

The effect of food depends on the physicochemical and pharmacokinetic characteristics of the drugs.1 The clinical significance of the effect will in turn depend on the pharmacodynamic characteristics of the drug. For example, the poorly water soluble antiretroviral drug saquinavir should be taken with food to allow bile enhancement of its dissolution which then facilitates absorption. The extent of absorption is more than doubled by taking saquinavir after a full cooked breakfast. Taking saquinavir on an empty stomach reduces its bioavailability and could lead to therapeutic failure.1

Delayed gastric emptying after a meal and the associated gastric acid secretions can reduce the bioavailability of some medicines that are acid labile. The constituents of a meal may also specifically interact with drugs (Table 2). Calcium and other cations in food can form insoluble chelates with some medicines preventing their optimal absorption. Bisphosphonates are therefore recommended to be taken with plain water to prevent the formation of chelates which significantly reduce bioavailability.

Source:

 Aust Prescr 2006;29:40-2 | 1 April 2006 | http://dx.doi.org/10.18773/austprescr.2006.026

Andrew McLachlan and Iqbal Ramzan, Faculty of Pharmacy, University of Sydney, NSW

 


Comments:

Take your digestive enzymes and acidophilus before a meal to increase bioavailability and be present in our body before we ingest food so that these enzymes and supplements can be more beneficial. Do take fat-rich meal with Vit E, D, K and A.  And always have Vitamin C rich foods with meals as it helps in the absorption of nutrients.

Do not eat/drink grapefruit when taking any meds/drugs as it doubles their potency.